Back to Search
ANDREW MILLER, D.M.D
D.M.D
Dentist
NPI: 1417123654IndividualAccepts Medicare
Specialties, Licenses & Credentials
Oral and Maxillofacial Surgery (Dentist)
Dentist — Oral and Maxillofacial Surgery
Code: 1223S0112X
DS037837(PA)
DentistPrimary
Dentist
Code: 122300000X
DS037837(PA)
CMS Specialties
PrimaryORAL SURGERY
Additional
MAXILLOFACIAL SURGERY
Education
OTHER
Class of 2012
Clinical Trials (4)
4
Linked Trials
0
Recruiting
4
With Results
A Study of Infliximab for Treatment Resistant Major Depression
NCT00463580COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
NCT04352101COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation
NCT02796755COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
NCT00352885COMPLETEDPHASE4STUDY_CHAIR
Research & Publications (20)
Antidepressants for the treatment of depression in people with cancer.
PMID 36999619·Cochrane Database Syst Rev·2023
6-review
Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation.
PMID 25529904·Brain Behav Immun·2015
2-rct
The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings.
PMID 23575741·Neuropsychopharmacology·2013
2-rct
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
PMID 22945416·JAMA Psychiatry·2013
4-observational
Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.
PMID 23624296·Brain Behav Immun·2013
2-rct
Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
PMID 22353759·Neuropsychopharmacology·2012
4-observational
Switching statin therapy using a pharmacist-managed therapeutic conversion program versus usual care conversion among indigent patients.
PMID 18447653·Pharmacotherapy·2008
3-trial
Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria.
PMID 19517101·Eur J Clin Pharmacol·2009
3-trial
Fluorescence cross-correlation spectroscopy as a universal method for protein detection with low false positives.
PMID 19522509·Anal Chem·2009
8-other
Identification of protein cofactors necessary for sequence-specific plasmid DNA nuclear import.
PMID 19532138·Mol Ther·2009
8-other
Incidence of ceramic liner malseating in Trident acetabular shell.
PMID 19280269·Clin Orthop Relat Res·2009
8-other
Lip reconstruction with combined cutaneous and mucosal pedicle flaps.
PMID 19438674·Dermatol Surg·2009
5-case
Zirconocene-mediated macrocyclizations of diynes containing di-o-methylphenylene spacers.
PMID 19323577·J Org Chem·2009
8-other
Dual-energy X-ray absorptiometry is the method of choice to assess body composition in COPD.
PMID 19353776·Respirology·2009
4-observational
Mesityl alkyne substituents for control of regiochemistry and reversibility in zirconocene couplings: new synthetic strategies for unsymmetrical zirconacyclopentadienes and conjugated polymers.
PMID 19296582·J Am Chem Soc·2009
8-other
Histologic and immunohistochemical characterization of pheochromocytoma in 6 cotton-top tamarins (Saguinus oedipus).
PMID 19605896·Vet Pathol·2009
7-preclinical
How word decoding skill impacts text memory: The centrality deficit and how domain knowledge can compensate.
PMID 19475514·Ann Dyslexia·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1601 WALNUT ST STE 215
PHILADELPHIA, PA 19102 - Phone
- (215) 557-7949
Quick Facts
- NPI
- 1417123654
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 14
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile